ATOSSA THERAPEUTICS, INC. — Director's Dealing 2013

Mar 13, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ATOSSA GENETICS INC (ATOS)
CIK: 0001488039
Period of Report: 2013-03-11

Reporting Person: Chen Shu-Chih (Director, CSO, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-03-11	Stock Option (right to buy)	$6.57	A	26516	Acquired	2023-03-11	Common Stock (26516)	Direct

Footnotes

F1: On March 11, 2013, the Board of Directors approved a grant to the Reporting Person to purchase an aggregate of 26,516 shares of Common Stock, fully vested and exercisable as of the date of grant. This option was granted in full satisfaction of a cash bonus payable to the Reporting Person for services in 2012 as the CSO of the Issuer.